Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, that's good but those sells are through on-line third party entities, right? But what would be super great if Target, Wal-Mart, CVS, Walgreen, and other big boys stock and provide Actipatch direct. Huh!!
GLTA!!!
BIEL should place ALLAY on the FDA Challenge list for Nov selection. I wonder if they will.
GLTA!!!
Thanks! Appreciate the feedback!
GLTA!!!
Hmm! Just what is the intended effect of this "FDA innovation challenge" deal? Of course, the FDA has defined it, so does anybody know the definition of the "challenge"? One would think this new feature within the process would at least offer means to help expedite the process, right? But in this world, who knows!!
GLTA!!!
Very comprehensive feedback! Thanks A Mil!!
GLTA!!!
Is the "All Musculoskeletal Pain" Actipatch device also subject to this "Challenge" thing, as well? I'm sorry, I don't understand why this "challenge" thing was added into the mix here? Maybe I missed something during the translation of why this is good for BIEL. Can someone help me out here? Did the CEO, during his latest interview, expound on why this recent FDA requirement was implemented, and maybe how it's beneficial to BIEL? To reiterate, can someone clarify just how does the "All Musculoskeletal Pain" clearance play within these new developments?
GLTA!!!
Interesting Post! I agree!!
GLTA!!!
Hmm! Yes! kinda strange! The 'innovation challenge' angle was obviously inserted into the equation by the FDA. So, what was their motive for doing so? I hope it's not a setup for further FDA goldbricking to forestall BIEL's full clearance, which by all accounts, should have occurred in the past some time ago. One must admit, this is an odd new development. Thus, why should BIEL be thrown in the hopper with other players, at this particular juncture, in order to get selected for clearance. Good Question, Huh! It sound like someone is getting wrapped around the proverbial axle, and guess who? IMO, this latest bit of shell game, FDA style, should be watched very closely. Just maybe this is another insidious gambit by the FDA to "punk" BIEL. If BIEL does not get full clearance after this little apparent sleight-of-hand by the FDA, then maybe BIEL should file a complaint of some kind. Yes, that would be a risky move, but this BIEL/FDA saga has to have a conclusion. Furthermore, if BIEL does not get full clearance after this current delay, then it would be crystal clear that the Big Pharma Tail is wagging the "FDA Dog". There will be no doubt about it! That's my take!!
GLTA!!!
P.S. Think for yourselves and let others enjoy the privilege to do so, too.
-Voltaire-
No, you shouldn't be that guy!! LOL!
The FDA should be held to account for why they are protracting the process of finalizing BIEL's product clearance! If there is a valid reason for this, then they should state it!
GLTA!!!
Yes, after so many years of hard work to arrive at this juncture of BIEL's development, it would be understandable that the CEO would resist a voluntary takeover. But, because of BIEL's share structure, would a hostile takeover be possible, which hopefully doesn't happen.
GLTA!!!
Let's engage in some "What If's", if you will! So, if and when BIEL receives full clearance, it's likely it will be bought out by a significant business entity such as, Google, Amazon, Microsoft or some big Phama player. Does anyone disagree with the aforementioned? Furthermore, if BIEL is indeed bought out, the PPS would approach $1.OO over night. Thus, does anyone disagree with that assumption?
GLTA!!!
Why not ask this board? I thought the purpose of a board like this is to propagate information. Thus, some members seem to have a communication conduit directly to officials there. So, why not query board members regarding their contacts within BIEL? In fact, I think it's more efficient to have a few voices from this board communicating with Keith and/or others at BIEL, than to have everybody and their mama to weight in with emails and such. Just My Take!!
GLTA!!!
Ok! Thanks!
Has anybody on this board ever pose the following question to Keith, are any other BIEL official? Thus, when do you plan to launch a serious AD campaign? Furthermore, if you are not planning an AD campaign directed from in-house, then could you disclose your planned alternative method to get the word out? Whatever the answers to those questions are, it will go a long way in tamping down bewilderment and speculation.
GLTA!!!
Don't get it! This article was published on, 04-28-2008. So, why is that article relevant now? Just asking!
GLTA!!!
Thanks DB! Sometimes we drop our guard and get taken! My Bad!
GLTA!!!
"Unfortunately BIEL has yet to file 510k clearances due to resource constraints (only 2 people working on it). " If what you say is true, that's pathetic!
GLTA!!!
Well, yes, but the advertisement component is the key to maximizing sales. Billions aren't spent each year willy-nilly; it's targeted and scientific.
GLTA!!!
P.S. If BIEL had an aggressive ad campaign currently running, I would dare say the PPS would be very, very, strong indeed.
Very funny!
Please, if you will, recap that which the SC will be rendering a decision.
Thanks!
GLTA!!
Can't understand why he is tweeting this stuff. If he and the rest of BIEL's officials have this thing under contron, just sit back and wait for the confetti to fall. Please! My Goodness! Just Strange!
GLTA!!!
If BIEL's stock doesn't show an exceptional upward trend upon, hopefully, receiving FDA "full-body" clearance for muscle and joint, then I think the debate will be over regarding the reason why the stock hasn't yet reached its rightful heights.
Please excuse the protracted sentence!
GLTA!!!
The lack of sales increase isn't the only reason why this stock doesn't move. There are technical reasons why this is happening. There are some on this board who don't want to broach this issue, but it's quite evident the technical areas which I've adduced in the past are the likely culprits. I posit that if these areas are not remedied, they will continue to be a major drag on this company's stock upward trend. Just My Take!!
GLTA!!!
Well if that's the case, shouldn't BIEL officials be out front complaining about it?
GLTA!!!
Agree! Why was that tweet necessary? Is somebody playing games here? At this stage of BIEL's storied saga to get full clearance for its products, I wouldn't expect anyone from BIEL's "Mahogany Row" to be asking for help from shareholders, via their tweets. What's going on here?
GLTA!!!
What the heck is he talking about? I was under the impression that he and his cohorts at BIEL have this situation under control. Oh, yes, general clearance is on the verge, and all is good, right? So why is the Sales VP asking for help from the sidelines? I'm sorry, this is quite strange!
GLTA!!!
What?!
Hey! Google, Microsoft, do you want to play?
GLTA!!!
Could anybody be as incompetent as the ex-CEO of REVO appears to be? This whole thing must have been planned from the very beginning! Can anyone say FRAUD!! That's My Take!
As I understand it, Eyetalk365 is not a publicly traded stock. So where do Eyetalk shareholders figure into this situation?
Sorry, I didn't see anywhere on the Oracle Dispatch site where BIEL stock was declared #1 to buy. I guess I must have over looked it some how.
GLTA!!!
Sorry, I thought your link would take me to the "Oracle Dispatch" site, not Yahoo Fin. Thanks anyway!
GLTA!!!
This "Barchart" thing, IMO, is pretty much useless. From day-to-day, it's all over the place. That's My Take!
GLTA!!!
Please provide the link to that statement by "Oracle Dispatch".
Thanks!
GLTA!!!
35! Well, that's not a particularly high bar, considering what's expected to transpire between BIEL and the FDA this week. Hopefully, we will get good news by week's end.
GLTA!!!
I think us BIEL'ers all, are very pleased with the current and upcoming activities associated with the company's good fortunes. But, IMO, the relative low performance of BIEL's stock just doesn't make sense, especially in the midst of all this fantastic news surrounding BIEL. If the bloated O/S count, and/ the legal cloud which hangs over the owner-family business activities are not the impetus for the stock's less than stellar performance, then what is the reason(s)? If someone can possibly provide a plausible technical reason for this, other than that which was alluded to herein, it would be a help with understanding it all.
GLTA!!!
Specifically, where in that article BIEL is being featured?
GLTA!!!
Well, considering the manner in which the FDA listed the subject items (i.e., Actipatch therapy, ALLAY & RecoveryRx, as per their registration website, we should probably expect some spectacular news soon after the May 29th meeting. IMO, there is the possibility the Bayer/Dr. Scholl's deal will be included in a stunning four leafed PR clover. There probably won't be any significant PR material published by BIEL until soon after the upcoming meeting. That's my take!!
GO! BIEL!!
GLTA!!!
DB, Point taken!
GLTA!!!